Importance of cyclosporine dosage and blood levels in simultaneous pancreas and kidney transplant success.
Cantarovich
D
D
Service de Néphrologie et Immunologie Clinique Transplantation, Centre Hospitalier et Universitaire de Nantes, France.
Dantal
J
J
Hourmant
M
M
Baatard
R
R
Paineau
J
J
Murat
A
A
Soulillou
J P
JP
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007376:Interleukin-2 / Q000378:metabolism; D016030:Kidney Transplantation; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000276:immunology; D014511:Uremia / Q000601:surgery
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone